Quantcast

Latest Chris Takimoto Stories

2007-08-08 12:09:12

Chris H. M. Takimoto, M.D., Ph.D., an internationally recognized leader in the development of new anti-cancer drugs, has been named director of pharmacology at South Texas Accelerated Research Therapeutics (START). Dr. Takimoto comes to START from the Cancer Therapy & Research Center's Institute for Drug Development, where he was pharmacology director and held the Zachry Chair of Translational Research. START, a clinical research organization focused on developing new anti-cancer...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related